靶标-话题@MedSci

#靶标#

218篇内容 | 1831人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1352876, encodeId=d43913528e6a9, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Commun：武汉大学等多单位合作！钟波/林丹丹/褚倩揭示非小细胞肺癌新的潜在的治疗靶标, objectType=article, longId=205075, objectId=1ee02050e539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ee02050e539, replyNumber=0, likeNumber=65, createdTime=2021-01-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ee02050e539, moduleTitle=Nat Commun：武汉大学等多单位合作！钟波/林丹丹/褚倩揭示非小细胞肺癌新的潜在的治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ee02050e539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352875, encodeId=994e13528e58e, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Br J Cancer：HOX基因：肾上腺皮质癌的潜在治疗靶标, objectType=article, longId=203700, objectId=8772203e000b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8772203e000b, replyNumber=0, likeNumber=29, createdTime=2020-11-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8772203e000b, moduleTitle=Br J Cancer：HOX基因：肾上腺皮质癌的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8772203e000b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352874, encodeId=227813528e4ea, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell rep：导致痛经和不孕的子宫内膜异位症的治疗靶标被发现, objectType=article, longId=203438, objectId=5c9520343833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c9520343833, replyNumber=0, likeNumber=37, createdTime=2020-11-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c9520343833, moduleTitle=Cell rep：导致痛经和不孕的子宫内膜异位症的治疗靶标被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c9520343833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352873, encodeId=bea313528e336, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell Death Differ：间充质干细胞移植技术揭示外泌体miR-21或可成为视网膜变性的潜在治疗靶标, objectType=article, longId=203016, objectId=61bf20301671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61bf20301671, replyNumber=0, likeNumber=21, createdTime=2020-11-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61bf20301671, moduleTitle=Cell Death Differ：间充质干细胞移植技术揭示外泌体miR-21或可成为视网膜变性的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61bf20301671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352872, encodeId=008913528e2bc, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell Metab ：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！, objectType=article, longId=202507, objectId=96bd20250ec7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96bd20250ec7, replyNumber=0, likeNumber=30, createdTime=2020-10-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96bd20250ec7, moduleTitle=Cell Metab ：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96bd20250ec7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352871, encodeId=c80713528e1dd, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Commun :重大进展！中山大学蔡俊超/吴珏珩发现肺腺癌新的潜在治疗靶标, objectType=article, longId=202413, objectId=875f20241317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875f20241317, replyNumber=0, likeNumber=27, createdTime=2020-10-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875f20241317, moduleTitle=Nat Commun :重大进展！中山大学蔡俊超/吴珏珩发现肺腺癌新的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875f20241317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352870, encodeId=da5113528e034, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标, objectType=article, longId=201820, objectId=4b5c201820da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b5c201820da, replyNumber=0, likeNumber=31, createdTime=2020-10-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b5c201820da, moduleTitle=Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b5c201820da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352869, encodeId=b8d7135286965, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Commun：MCL-1或可成为肺腺癌的潜在治疗靶标, objectType=article, longId=201085, objectId=040e2010852b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040e2010852b, replyNumber=0, likeNumber=31, createdTime=2020-09-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040e2010852b, moduleTitle=Nat Commun：MCL-1或可成为肺腺癌的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=040e2010852b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352868, encodeId=2a1d1352868d4, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Br J Cancer：FOXP3和PD-L1或可成为化生性乳腺癌的潜在治疗靶标, objectType=article, longId=201081, objectId=876620108126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=876620108126, replyNumber=0, likeNumber=37, createdTime=2020-09-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=876620108126, moduleTitle=Br J Cancer：FOXP3和PD-L1或可成为化生性乳腺癌的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=876620108126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352867, encodeId=fdf2135286ea1, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Commun：TMEM16A：常染色体显性多囊肾的治疗靶标！, objectType=article, longId=200498, objectId=2b6e2004986a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b6e2004986a, replyNumber=0, likeNumber=37, createdTime=2020-09-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b6e2004986a, moduleTitle=Nat Commun：TMEM16A：常染色体显性多囊肾的治疗靶标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b6e2004986a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352866, encodeId=4e6513528664f, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Gastroenterology：胰腺癌的新药物靶标——PPP1R1B蛋白, objectType=article, longId=199139, objectId=167d199139e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=167d199139e2, replyNumber=0, likeNumber=36, createdTime=2020-08-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=167d199139e2, moduleTitle=Gastroenterology：胰腺癌的新药物靶标——PPP1R1B蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=167d199139e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352865, encodeId=135b13528654d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Rev Neurol：卒中生物标志物和治疗靶标的多组学综述, objectType=article, longId=195857, objectId=7ef219585ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ef219585ee7, replyNumber=0, likeNumber=49, createdTime=2020-06-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ef219585ee7, moduleTitle=Nat Rev Neurol：卒中生物标志物和治疗靶标的多组学综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ef219585ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352864, encodeId=47dc13528643b, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Oncogenesis：口服联用药物靶向肾细胞肿瘤的分子靶标 , objectType=article, longId=195703, objectId=76d8195e033c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76d8195e033c, replyNumber=0, likeNumber=29, createdTime=2020-06-13, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76d8195e033c, moduleTitle=Oncogenesis：口服联用药物靶向肾细胞肿瘤的分子靶标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76d8195e033c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352863, encodeId=bb5b13528631b, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标, objectType=article, longId=194074, objectId=e9d11940e4df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9d11940e4df, replyNumber=0, likeNumber=26, createdTime=2020-05-14, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9d11940e4df, moduleTitle=Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9d11940e4df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352862, encodeId=214b1352862ea, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台, objectType=article, longId=193917, objectId=af9919391eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9919391eba, replyNumber=0, likeNumber=30, createdTime=2020-05-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9919391eba, moduleTitle=Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9919391eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352861, encodeId=2c721352861c8, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标, objectType=article, longId=193754, objectId=a0f4193e5449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0f4193e5449, replyNumber=0, likeNumber=30, createdTime=2020-05-10, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0f4193e5449, moduleTitle=新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0f4193e5449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352860, encodeId=5f01135286088, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell Death Diff：抑制ErbB2内吞降解的去泛素化酶USP2可作为ErbB2阳性乳腺癌的治疗靶标, objectType=article, longId=193625, objectId=599e1936251e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=599e1936251e, replyNumber=0, likeNumber=30, createdTime=2020-05-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=599e1936251e, moduleTitle=Cell Death Diff：抑制ErbB2内吞降解的去泛素化酶USP2可作为ErbB2阳性乳腺癌的治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=599e1936251e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352859, encodeId=0fc6135285938, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Oncogene：PAK4可作为膀胱癌的治疗靶标 , objectType=article, longId=192504, objectId=82fa19250435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82fa19250435, replyNumber=0, likeNumber=41, createdTime=2020-04-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82fa19250435, moduleTitle=Oncogene：PAK4可作为膀胱癌的治疗靶标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82fa19250435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352858, encodeId=a0ee1352858f5, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=科学家发现COVID-19新药物靶标！, objectType=article, longId=190732, objectId=5f98190e328e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f98190e328e, replyNumber=0, likeNumber=34, createdTime=2020-03-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f98190e328e, moduleTitle=科学家发现COVID-19新药物靶标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f98190e328e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352857, encodeId=a613135285eea, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell death dis：胶质母细胞瘤干细胞迁移的关键分子靶标——Rap1a, objectType=article, longId=190234, objectId=a8101902349a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8101902349a, replyNumber=0, likeNumber=31, createdTime=2020-03-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8101902349a, moduleTitle=Cell death dis：胶质母细胞瘤干细胞迁移的关键分子靶标——Rap1a, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8101902349a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶标

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Commun：武汉大学等多单位合作！钟波/林丹丹/褚倩揭示非小细胞肺癌新的潜在的治疗靶标

2021-01-02

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Br J Cancer：HOX基因：肾上腺皮质癌的潜在治疗靶标

2020-11-26

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell rep：导致痛经和不孕的子宫内膜异位症的治疗靶标被发现

2020-11-17

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell Death Differ：间充质干细胞移植技术揭示外泌体miR-21或可成为视网膜变性的潜在治疗靶标

2020-11-08

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell Metab ：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！

2020-10-27

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Commun :重大进展！中山大学蔡俊超/吴珏珩发现肺腺癌新的潜在治疗靶标

2020-10-24

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标

2020-10-09

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Commun：MCL-1或可成为肺腺癌的潜在治疗靶标

2020-09-24

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Br J Cancer：FOXP3和PD-L1或可成为化生性乳腺癌的潜在治疗靶标

2020-09-24

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Commun：TMEM16A：常染色体显性多囊肾的治疗靶标！

2020-09-11

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Gastroenterology：胰腺癌的新药物靶标——PPP1R1B蛋白

2020-08-12

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Rev Neurol：卒中生物标志物和治疗靶标的多组学综述

2020-06-15

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Oncogenesis：口服联用药物靶向肾细胞肿瘤的分子靶标

2020-06-13

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标

2020-05-14

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Acta Pharmaceutica Sinica B：上海药物所开发抗新冠肺炎药物靶标预测及虚拟筛选网络应用平台

2020-05-12

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标

2020-05-10

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell Death Diff：抑制ErbB2内吞降解的去泛素化酶USP2可作为ErbB2阳性乳腺癌的治疗靶标

2020-05-08

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Oncogene：PAK4可作为膀胱癌的治疗靶标

2020-04-20

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

科学家发现COVID-19新药物靶标！

2020-03-26

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell death dis：胶质母细胞瘤干细胞迁移的关键分子靶标——Rap1a

2020-03-19

科室
- - 订阅+
  - 更多科室
工具
服务